OIL 0.00% 6.0¢ optiscan imaging limited

phase three trials

  1. 2,492 Posts.
    lightbulb Created with Sketch. 10
    This is good news. Looks like two trials from the Barrow institute to assess 5-ALA fluorescence agent with confocal microscope in brain surgery. This would be the phase 3 confirmatory trial. The primary completion date may have already passed

    Column 1 Column 2
    0 Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

    https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=1

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=721822&version=Patient

    https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=2


    https://www.clinicaltrials.gov/ct2/...or Low- and High-grade Gliomas &Search=Search

    Whatever the traders are doing atm won`t matter with positive outcomes from these trials.
 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
0.00(0.00%)
Mkt cap $25.96M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 34030 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 7937 1
Last update - 12.29pm 16/10/2018 (20 minute delay) ?
OIL (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.